This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Boston Scientific's Median PS Value or its related term are showing as below:
BSX'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.02 Med: 1.55 Max: 2.49
Current: 1.69
During the past 13 years, the highest Price to Median PS Value of Boston Scientific was 2.49. The lowest was 1.02. And the median was 1.55.
BSX's Price-to-Median-PS-Value is ranked worse than 91.48% of 317
companies
in the Medical Devices & Instruments industry
Industry Median: 0.75
vs BSX: 1.69
Boston Scientific Median PS Value Historical Data
The historical data trend for Boston Scientific's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Boston Scientific's Median PS Value
For the Medical Devices subindustry, Boston Scientific's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Boston Scientific's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 5.2477.
Boston Scientific's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.79.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (NYSE:BSX) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Boston Scientific's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
104.32
/
61.87
=
1.69
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific Median PS Value Related Terms
Thank you for viewing the detailed overview of Boston Scientific's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSX has been successfully added to your 